Business
Press Release Nov 17 2021
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 17, 2021, titled "Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited receives USFDA Final Approval for Mupirocin Cream USP, 2%".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 17, 2021, titled \"Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited receives USFDA Final Approval for Mupirocin Cream USP, 2%\". View Attachment","length":446,"tagName":"div"}]